Ketolek (Ketoprofen)

Ketoprofen works by reversibly inhibiting cyclooxygenase‑1 and cyclooxygenase‑2 enzymes, which are essential for prostaglandin production. Lower prostaglandin levels lead to reduced inflammation, pain signaling, and fever, providing therapeutic benefit in inflammatory conditions.

The specific dose of Ketolek is determined by the prescribing healthcare professional based on the individual’s condition, severity, and response. Dosage recommendations follow the approved labeling for ketoprofen and should be individualized by the prescriber.

Ketoprofen, like other NSAIDs, is generally avoided during the third trimester of pregnancy due to potential fetal risks. Safety in early pregnancy and lactation has not been fully established, so clinicians should weigh benefits against possible risks and consider alternative therapies when appropriate.

To order Ketolek, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details, and any necessary import documentation.

Ketolek (ketoprofen) and ibuprofen belong to the same NSAID class but differ in potency and pharmacokinetics. Ketoprofen often provides longer‑lasting analgesia and may be more effective for certain inflammatory conditions, while ibuprofen is widely used for mild pain with a shorter half‑life. Choice depends on clinical response, safety profile, and physician preference.

Ketolek should be stored at ambient temperature, preferably below 25 °C. Keep the product in its original packaging, protect it from moisture and direct sunlight, and ensure the container is tightly closed to maintain stability.

Ketolek is taken orally, usually with a full glass of water. It may be taken with or without food, but patients who experience stomach upset are advised to ingest it with meals to minimize gastrointestinal irritation.

Serious risks include gastrointestinal bleeding or ulceration, acute kidney injury, severe liver injury, life‑threatening skin reactions such as Stevens‑Johnson syndrome, and anaphylaxis. Patients should be monitored for signs of these events, especially if they have pre‑existing risk factors.

Ketolek is contraindicated in individuals with known hypersensitivity to ketoprofen or other NSAIDs, active gastrointestinal bleeding or ulcer disease, severe renal or hepatic impairment, and in the third trimester of pregnancy. Caution is also advised for patients on anticoagulants or other NSAIDs.